Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -14.80% is 43% above its 2-year average of -25.91%, near the high end of its 2-year range (-41.24%–-14.80%).
As of the fiscal period ended Wednesday, December 31, 2025. 47.18% above its 12-month average of -28.02%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
-14.80%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-28.02%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+47.18%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-273.51%
vs the sector median at left
Shoulder Innovations, Inc.
Market Cap
$468.68M
Return on Invested Capital (ROIC)
-14.80%
TTM Avg
-28.02%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$440.37M
Return on Invested Capital (ROIC)
14.36%
TTM Avg
20.25%
3Y Avg
26.82%
5Y Avg
29.14%
Market Cap
$15.31M
Return on Invested Capital (ROIC)
-553.10%
TTM Avg
-332.89%
3Y Avg
-182.55%
5Y Avg
-143.76%
Market Cap
$1.26B
Return on Invested Capital (ROIC)
-8.26%
TTM Avg
-20.40%
3Y Avg
-90.85%
5Y Avg
-61.23%
Market Cap
$2.64B
Return on Invested Capital (ROIC)
10.94%
TTM Avg
7.96%
3Y Avg
-0.14%
5Y Avg
-9.11%
Market Cap
$2.76B
Return on Invested Capital (ROIC)
5.67%
TTM Avg
-6.15%
3Y Avg
-6.50%
5Y Avg
-3.41%
Market Cap
$7.06B
Return on Invested Capital (ROIC)
6.02%
TTM Avg
9.35%
3Y Avg
-2.77%
5Y Avg
-9.72%
Market Cap
$7.81B
Return on Invested Capital (ROIC)
-27.10%
TTM Avg
-12.21%
3Y Avg
-19.73%
5Y Avg
-18.73%
Market Cap
$8.18B
Return on Invested Capital (ROIC)
-10.29%
TTM Avg
-59.01%
3Y Avg
-58.33%
5Y Avg
-53.58%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | $468.68M | -14.80% | -28.02% | N/A | N/A |
| NRC Health (NRC)vs › | $440.37M | 14.36% | 20.25% | 26.82% | 29.14% |
| 23andMe Holding Co. (ME)vs › | $15.31M | -553.10% | -332.89% | -182.55% | -143.76% |
| Teladoc Health, Inc. (TDOC)vs › | $1.26B | -8.26% | -20.40% | -90.85% | -61.23% |
| TransMedics Group, Inc. (TMDX)vs › | $2.64B | 10.94% | 7.96% | -0.14% | -9.11% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.76B | 5.67% | -6.15% | -6.50% | -3.41% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.06B | 6.02% | 9.35% | -2.77% | -9.72% |
| Oscar Health, Inc. (OSCR)vs › | $7.81B | -27.10% | -12.21% | -19.73% | -18.73% |
| Tempus AI, Inc. (TEM)vs › | $8.18B | -10.29% | -59.01% | -58.33% | -53.58% |
| Insulet Corp. (PODD)vs › | $9.23B | 13.62% | 12.65% | 8.97% | 7.27% |
ROIC
-14.8%
ROE
-33.1%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | -14.80% |
| 2024-12-31 | -41.24% |
| 2023-12-31 | -21.69% |
